Safety of light emitting diode-red light on human skin: Two randomized controlled trials

Jared Jagdeo, Julie K. Nguyen, Derek Ho, Erica B. Wang, Evan Austin, Andrew Mamalis, Ramanjot Kaur, Ekaterina Kraeva, Joshua M. Schulman, Chin Shang Li, Samuel T. Hwang, Ted Wun, Emanual Maverakis, R. Rivkah Isseroff

Research output: Contribution to journalArticle

Abstract

Therapeutic applications of light emitting diode-red light (LED-RL) are expanding, yet data on its clinical effects are lacking. Our goal was to evaluate the safety of high fluence LED-RL (≥160 J/cm2). In two phase I, single-blind, dose escalation, randomized controlled trials, healthy subjects received LED-RL or mock irradiation to the forearm thrice weekly for 3 weeks at fluences of 160-640 J/cm2 for all skin types (STARS 1, n = 60) and at 480-640 J/cm2 for non-Hispanic Caucasians (STARS 2, n = 55). The primary outcome was the incidence of adverse events (AEs). The maximum tolerated dose was the highest fluence that did not elicit predefined AEs. Dose-limiting AEs, including blistering and prolonged erythema, occurred at 480 J/cm2 in STARS 1 (n = 1) and 640 J/cm2 in STARS 2 (n = 2). AEs of transient erythema and hyperpigmentation were mild. No serious AEs occurred. We determined that LED-RL is safe up to 320 J/cm2 for skin of color and 480 J/cm2 for non-Hispanic Caucasian individuals. LED-RL may exert differential cutaneous effects depending on race and ethnicity, with darker skin being more photosensitive. These findings may guide future studies to evaluate the efficacy of LED-RL for the treatment of various diseases.

Original languageEnglish (US)
Article numbere201960014
JournalJournal of Biophotonics
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Light emitting diodes
safety
Skin
light emitting diodes
Randomized Controlled Trials
Safety
Light
fluence
dosage
forearm
Erythema
incidence
Irradiation
Color
Skin Pigmentation
color
Hyperpigmentation
irradiation
Maximum Tolerated Dose
Forearm

Keywords

  • low-level light therapy
  • phototherapy
  • randomized controlled trial
  • skin pigmentation

ASJC Scopus subject areas

  • Chemistry(all)
  • Materials Science(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Engineering(all)
  • Physics and Astronomy(all)

Cite this

Jagdeo, J., Nguyen, J. K., Ho, D., Wang, E. B., Austin, E., Mamalis, A., ... Isseroff, R. R. (Accepted/In press). Safety of light emitting diode-red light on human skin: Two randomized controlled trials. Journal of Biophotonics, [e201960014]. https://doi.org/10.1002/jbio.201960014

Safety of light emitting diode-red light on human skin : Two randomized controlled trials. / Jagdeo, Jared; Nguyen, Julie K.; Ho, Derek; Wang, Erica B.; Austin, Evan; Mamalis, Andrew; Kaur, Ramanjot; Kraeva, Ekaterina; Schulman, Joshua M.; Li, Chin Shang; Hwang, Samuel T.; Wun, Ted; Maverakis, Emanual; Isseroff, R. Rivkah.

In: Journal of Biophotonics, 01.01.2019.

Research output: Contribution to journalArticle

Jagdeo, J, Nguyen, JK, Ho, D, Wang, EB, Austin, E, Mamalis, A, Kaur, R, Kraeva, E, Schulman, JM, Li, CS, Hwang, ST, Wun, T, Maverakis, E & Isseroff, RR 2019, 'Safety of light emitting diode-red light on human skin: Two randomized controlled trials', Journal of Biophotonics. https://doi.org/10.1002/jbio.201960014
Jagdeo, Jared ; Nguyen, Julie K. ; Ho, Derek ; Wang, Erica B. ; Austin, Evan ; Mamalis, Andrew ; Kaur, Ramanjot ; Kraeva, Ekaterina ; Schulman, Joshua M. ; Li, Chin Shang ; Hwang, Samuel T. ; Wun, Ted ; Maverakis, Emanual ; Isseroff, R. Rivkah. / Safety of light emitting diode-red light on human skin : Two randomized controlled trials. In: Journal of Biophotonics. 2019.
@article{ea592dd424114d3686b24d9405e30b76,
title = "Safety of light emitting diode-red light on human skin: Two randomized controlled trials",
abstract = "Therapeutic applications of light emitting diode-red light (LED-RL) are expanding, yet data on its clinical effects are lacking. Our goal was to evaluate the safety of high fluence LED-RL (≥160 J/cm2). In two phase I, single-blind, dose escalation, randomized controlled trials, healthy subjects received LED-RL or mock irradiation to the forearm thrice weekly for 3 weeks at fluences of 160-640 J/cm2 for all skin types (STARS 1, n = 60) and at 480-640 J/cm2 for non-Hispanic Caucasians (STARS 2, n = 55). The primary outcome was the incidence of adverse events (AEs). The maximum tolerated dose was the highest fluence that did not elicit predefined AEs. Dose-limiting AEs, including blistering and prolonged erythema, occurred at 480 J/cm2 in STARS 1 (n = 1) and 640 J/cm2 in STARS 2 (n = 2). AEs of transient erythema and hyperpigmentation were mild. No serious AEs occurred. We determined that LED-RL is safe up to 320 J/cm2 for skin of color and 480 J/cm2 for non-Hispanic Caucasian individuals. LED-RL may exert differential cutaneous effects depending on race and ethnicity, with darker skin being more photosensitive. These findings may guide future studies to evaluate the efficacy of LED-RL for the treatment of various diseases.",
keywords = "low-level light therapy, phototherapy, randomized controlled trial, skin pigmentation",
author = "Jared Jagdeo and Nguyen, {Julie K.} and Derek Ho and Wang, {Erica B.} and Evan Austin and Andrew Mamalis and Ramanjot Kaur and Ekaterina Kraeva and Schulman, {Joshua M.} and Li, {Chin Shang} and Hwang, {Samuel T.} and Ted Wun and Emanual Maverakis and Isseroff, {R. Rivkah}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/jbio.201960014",
language = "English (US)",
journal = "Journal of Biophotonics",
issn = "1864-063X",
publisher = "Wiley-VCH Verlag",

}

TY - JOUR

T1 - Safety of light emitting diode-red light on human skin

T2 - Two randomized controlled trials

AU - Jagdeo, Jared

AU - Nguyen, Julie K.

AU - Ho, Derek

AU - Wang, Erica B.

AU - Austin, Evan

AU - Mamalis, Andrew

AU - Kaur, Ramanjot

AU - Kraeva, Ekaterina

AU - Schulman, Joshua M.

AU - Li, Chin Shang

AU - Hwang, Samuel T.

AU - Wun, Ted

AU - Maverakis, Emanual

AU - Isseroff, R. Rivkah

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Therapeutic applications of light emitting diode-red light (LED-RL) are expanding, yet data on its clinical effects are lacking. Our goal was to evaluate the safety of high fluence LED-RL (≥160 J/cm2). In two phase I, single-blind, dose escalation, randomized controlled trials, healthy subjects received LED-RL or mock irradiation to the forearm thrice weekly for 3 weeks at fluences of 160-640 J/cm2 for all skin types (STARS 1, n = 60) and at 480-640 J/cm2 for non-Hispanic Caucasians (STARS 2, n = 55). The primary outcome was the incidence of adverse events (AEs). The maximum tolerated dose was the highest fluence that did not elicit predefined AEs. Dose-limiting AEs, including blistering and prolonged erythema, occurred at 480 J/cm2 in STARS 1 (n = 1) and 640 J/cm2 in STARS 2 (n = 2). AEs of transient erythema and hyperpigmentation were mild. No serious AEs occurred. We determined that LED-RL is safe up to 320 J/cm2 for skin of color and 480 J/cm2 for non-Hispanic Caucasian individuals. LED-RL may exert differential cutaneous effects depending on race and ethnicity, with darker skin being more photosensitive. These findings may guide future studies to evaluate the efficacy of LED-RL for the treatment of various diseases.

AB - Therapeutic applications of light emitting diode-red light (LED-RL) are expanding, yet data on its clinical effects are lacking. Our goal was to evaluate the safety of high fluence LED-RL (≥160 J/cm2). In two phase I, single-blind, dose escalation, randomized controlled trials, healthy subjects received LED-RL or mock irradiation to the forearm thrice weekly for 3 weeks at fluences of 160-640 J/cm2 for all skin types (STARS 1, n = 60) and at 480-640 J/cm2 for non-Hispanic Caucasians (STARS 2, n = 55). The primary outcome was the incidence of adverse events (AEs). The maximum tolerated dose was the highest fluence that did not elicit predefined AEs. Dose-limiting AEs, including blistering and prolonged erythema, occurred at 480 J/cm2 in STARS 1 (n = 1) and 640 J/cm2 in STARS 2 (n = 2). AEs of transient erythema and hyperpigmentation were mild. No serious AEs occurred. We determined that LED-RL is safe up to 320 J/cm2 for skin of color and 480 J/cm2 for non-Hispanic Caucasian individuals. LED-RL may exert differential cutaneous effects depending on race and ethnicity, with darker skin being more photosensitive. These findings may guide future studies to evaluate the efficacy of LED-RL for the treatment of various diseases.

KW - low-level light therapy

KW - phototherapy

KW - randomized controlled trial

KW - skin pigmentation

UR - http://www.scopus.com/inward/record.url?scp=85076371436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076371436&partnerID=8YFLogxK

U2 - 10.1002/jbio.201960014

DO - 10.1002/jbio.201960014

M3 - Article

AN - SCOPUS:85076371436

JO - Journal of Biophotonics

JF - Journal of Biophotonics

SN - 1864-063X

M1 - e201960014

ER -